Description: Venture Life Group plc develops and commercializes healthcare products in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ brand. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos, as well as Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; Baby Earol, an ear spray for babies; and Sterinase for relieving blocked noses, clearing nasal passages, and preventing the risk of allergic reactions and infections. It also provides oncology support products, such as Pomi-T, used for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid based topical gel, for the prevention and treatment of Radiation Induced Dermatitis. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Home Page: www.venture-life.com
12 The Courtyard
Bracknell,
RG12 2XB
United Kingdom
Phone:
44 13 4457 8004
Officers
| Name | Title |
|---|---|
| Mr. Jeremy Anthony Philip Randall ACA | Co-Founder, CEO & Executive Director |
| Mr. Daniel James Wells | CFO & Director |
| Mr. Lodovico Gianluca Braguti | Chief Manufacturing Officer & Executive Director |
| Ben Colman | Director of Corporate Development |
| Mr. Domenico Barbaro | Head of Procurement |
| Mr. Ennio Schiro | Head of ESG Strategy |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 5.8651 |
|---|---|
| Trailing PE: | 43.4 |
| Price-to-Book MRQ: | 0.6155 |
| Price-to-Sales TTM: | 1.1122 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 165 |